PHARMACEUTICALS Gilead and Galapagos strike big R&D deal

被引:0
|
作者
Mccoy, Michael
机构
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:13 / 13
页数:1
相关论文
共 50 条
  • [31] Big Data and the Future of R&D Management
    Blackburn, Michael
    Alexander, Jeffrey
    Legan, J. David
    Klabjan, Diego
    RESEARCH-TECHNOLOGY MANAGEMENT, 2017, 60 (05) : 43 - 51
  • [32] Rebuilding the R&D engine in big pharma
    Garnier, Jean-Pierre
    HARVARD BUSINESS REVIEW, 2008, 86 (05) : 68 - +
  • [33] Rebuilding the R&D Engine in Big Pharma
    Green, Shawn J.
    HARVARD BUSINESS REVIEW, 2008, 86 (11) : 129 - 129
  • [34] Rebuilding the R&D Engine in Big Pharma
    Tu, Renjing
    HARVARD BUSINESS REVIEW, 2008, 86 (12) : 114 - 114
  • [35] The economic benefits of big science R&D: With a focus on fusion R&D program in Korea
    Choi, Wonjae
    Tho, Hyunsoo
    Kim, Youbean
    Hwang, Sungha
    Kang, Dongyup
    FUSION ENGINEERING AND DESIGN, 2017, 124 : 1263 - 1268
  • [36] The endless frontier? The recent increase of R&D productivity in pharmaceuticals
    Fabio Pammolli
    Lorenzo Righetto
    Sergio Abrignani
    Luca Pani
    Pier Giuseppe Pelicci
    Emanuele Rabosio
    Journal of Translational Medicine, 18
  • [37] Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents
    Patricia M. Danzon
    Adrian Towse
    International Journal of Health Care Finance and Economics, 2003, 3 (3): : 183 - 205
  • [38] R&D in today's pharmaceuticals industry: A case study
    Hesp, Barrie
    CEA : chemical engineering in Australia, 1988, 13 (03): : 20 - 24
  • [39] PHARMACEUTICALS Novo Nordisk to cut 400 R&D jobs
    Cross, Ryan
    CHEMICAL & ENGINEERING NEWS, 2018, 96 (38) : 15 - 15
  • [40] The endless frontier? The recent increase of R&D productivity in pharmaceuticals
    Pammolli, Fabio
    Righetto, Lorenzo
    Abrignani, Sergio
    Pani, Luca
    Pelicci, Pier Giuseppe
    Rabosio, Emanuele
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)